Study Of An Investigational Drug For Guillainbarré Syndrome
Seeking people aged 12 to 85 years old with GuillainBarré Syndrome who experience muscle weakness and who have not been treated with plasma exchange or IV immunoglobulin for a study of an investigational drug.